Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior

Details

Serval ID
serval:BIB_B09A00A6B4B0
Type
Article: article from journal or magazin.
Collection
Publications
Title
Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior
Journal
Transplantation
Author(s)
Niclauss N., Wojtusciszyn A., Morel P., Demuylder-Mischler S., Brault C., Parnaud G., Ris F., Bosco D., Badet L., Benhamou P. Y., Berney T.
ISSN
1534-6080 (Electronic)
ISSN-L
0041-1337
Publication state
Published
Issued date
2012
Volume
93
Number
7
Pages
703-8
Language
english
Notes
Niclauss, Nadja
Wojtusciszyn, Anne
Morel, Philippe
Demuylder-Mischler, Sandrine
Brault, Coralie
Parnaud, Geraldine
Ris, Frederic
Bosco, Domenico
Badet, Lionel
Benhamou, Pierre-Yves
Berney, Thierry
eng
Comparative Study
Research Support, Non-U.S. Gov't
Transplantation. 2012 Apr 15;93(7):703-8. doi: 10.1097/TP.0b013e3182476cc8.
Abstract
BACKGROUND: Institut Georges Lopez-1 (IGL-1) is a preservation solution similar to University of Wisconsin (UW) with reversed Na/K contents. In this study, we assessed the impact of IGL-1, UW, and Celsior (CS) solutions on islet isolation and transplant outcome. METHODS: We retrospectively analyzed 376 islet isolations from pancreases flushed and transported with IGL-1 (n=95), UW (n=204), or CS (n=77). We determined isolation outcome and beta-cell function in vitro. Transplanted patients were divided into three groups depending on preservation solution of pancreas, and islet graft function was assessed by decrease in daily insulin needs, C-peptide/glucose ratios, beta-scores, and transplant estimated function at 1- and 6-month follow-up. RESULTS: IGL-1, UW, and CS groups were similar according to donor age, body mass index, and pancreas weight. There was no difference in islet yields between the three groups. Success rates, transplant rates, beta-cell secretory function, and viability were similar for all three groups. We observed no difference in decreased insulin needs, C-peptide glucose ratios, beta-scores, and transplant estimated function at 1- and 6-month follow-up between IGL-1, UW, and CS groups. CONCLUSIONS: Our study shows that IGL-1 is equivalent to UW or CS solutions for pancreas perfusion and cold storage before islet isolation and transplantation.
Keywords
Adenosine/therapeutic use, Adult, Allopurinol/therapeutic use, Analysis of Variance, Biomarkers/blood, Blood Glucose/metabolism, C-Peptide/blood, Chi-Square Distribution, Diabetes Mellitus/blood/drug therapy/*surgery, Disaccharides/therapeutic use, Electrolytes/therapeutic use, Female, Glutamates/therapeutic use, Glutathione/therapeutic use, Glycated Hemoglobin A/metabolism, Histidine/therapeutic use, Humans, Hypoglycemic Agents/therapeutic use, Insulin/therapeutic use, Islets of Langerhans/*drug effects/metabolism, *Islets of Langerhans Transplantation, Male, Mannitol/therapeutic use, Middle Aged, Organ Preservation/*methods, Organ Preservation Solutions/*therapeutic use, Raffinose/therapeutic use, Retrospective Studies, Time Factors, Tissue Culture Techniques, Tissue and Organ Harvesting/*methods, Treatment Outcome
Pubmed
Create date
14/06/2021 9:59
Last modification date
18/09/2021 6:38
Usage data